Labverity
Facility profile

Dixon Investments Inc

Drug product manufacturing · Orchard Hill, GA

FDA recordFDA directory updated Jul 22, 2026Profile not yet claimed
Potential fit

Listed operations

The U.S. Food and Drug Administration (FDA) record lists broad activities for this site. Confirm specific services and availability directly.

Manufacture
Due diligence

Regulatory record at a glance

Use these records to guide qualification; they are not a facility score.

Registration record
Current FDA registration record

Expires Dec 31, 2026 · checked Jul 22, 2026

Latest matched inspection
Official action indicated (OAI)

Mar 11, 2025 · The findings may warrant official FDA action.

Matched compliance actions
Warning Letter · Sep 2025

Within five years · review the action and follow-up.

Understand this record

Use the evidence, then ask for fit.

Shows

Registration status and a latest matched official action indicated inspection.

Doesn’t show

Exact services, availability, capacity, pricing, or overall quality.

Ask next

Review the underlying findings, response, and subsequent follow-up before qualification.

Method and source details
View full inspection and compliance history6 inspection records

FDA inspection history

6 records, Jan 2010 – Mar 2025 · 0 NAI · 5 VAI · 1 OAI

DateClassProject areaCitationsFY
Mar 11, 2025OAIDrug Quality AssuranceYes2025
Mar 22, 2019VAIDrug Quality AssuranceYes2019
Dec 16, 2015VAIDrug Quality Assurance2016
Dec 6, 2013VAIDrug Quality Assurance2014
Dec 13, 2011VAIDrug Quality AssuranceYes2012
Jan 25, 2010VAIDrug Quality AssuranceYes2010

No action indicated (NAI) · Voluntary action indicated (VAI) · Official action indicated (OAI)

Matched compliance actions

Sep 18, 2025Warning Letter · CDER
Unclaimed profile

Service details not yet provided

Methods, equipment, quality scope, capacity, turnaround, and commercial contacts are not available.

Ask about services